- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02402517
PERFECT Project - Part 2 - Study 1
January 19, 2023 updated by: University of Manitoba
Pulse EnRiched Food and Exercise Clinical Trials (PERFECT Project): Part 2 - Acute Effects of Pulse Ingredients in Food Products on Aerobic Endurance and Substrate Oxidation During Exercise, as Well as, the Blood Glucose, Insulin, Lactate and Food Intake Response Following an Endurance Exercise Session in Adults - Study 1
The objectives are to test the acute effects of different extruded pulse snacks on: 1) aerobic endurance and substrate oxidation during exercise 2) response of blood glucose, insulin and appetite on an aerobic exercise session, and 3) food intake two hours following the exercise session.
The investigators hypothesize that consumption of food products containing pulse ingredients 60 minutes before exercise will increase aerobic endurance (lower oxygen consumption), decrease carbohydrate oxidation (greater respiratory quotient), and a reduction in lactate production during compared to the same exercise session following the ingestion of a non-pulse food.
The investigators also hypothesize that consumption of extruded pulse snacks will lead to lower blood glucose, insulin, appetite and food intake, suggesting lower calorie compensation, following a 60-minute aerobic exercise session compared to the same exercise session following the ingestion of a non-pulse food.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3T 2N2
- Richardson Centre for Functional Foods and Nutraceuticals
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Normoglycemic (<5.6 mmol/L) and normotensive (systolic blood pressure <140 mm Hg and diastolic blood pressure below < 90 mm Hg)
- BMI of 18.5-29.9 kg/m2
Exclusion Criteria:
- Restrained eaters
- Regularly skip breakfast
- Smokers
- Those who are active (organized activities or athletic training at a high intensity; ≥ 150 min per week of moderate to vigorous physical activity)
- Those on medications that may influence study outcomes or have experienced any gastrointestinal related health conditions/surgeries over the past year.
- Those unable to walk for an hour continuously
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Extruded snack control
100% corn flour
|
Non pulse extruded snack
|
Experimental: Extruded snack with small particle size pea flour
60% corn flour and 40% small particle size pea flour
|
Pulse extruded snack
|
Experimental: Extruded snack with large particle size pea flour
60% corn flour and 40% large particle size pea flour
|
Pulse extruded snack
|
Experimental: Extruded snack with lentil flour
60% corn flour and 40% lentil flour
|
Pulse extruded snack
|
Experimental: Extruded snack navy bean flour
60% corn flour and 40% navy bean flour
|
Pulse extruded snack
|
Experimental: Extruded snack with pinto bean flour
60% corn flour and 40% pinto bean flour
|
Pulse extruded snack
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Plasma Glucose and Insulin Concentrations
Time Frame: 0 - 240 min
|
Measured in blood using intravenous catheter at 14 time points, used to calculate area under curve (AUC).
Glucose will be determined by automated methods using Abbot Spectrum CCX Analyzer, and Insulin will be measured by commercially available RIA kits.
(Composite measure)
|
0 - 240 min
|
Food Intake
Time Frame: at 120 min
|
Ad-libitum meal.
Food consumed measured by weight.
|
at 120 min
|
Subjective Appetite
Time Frame: 0-240 min
|
Measured by VAS questionnaire at 14 time points, used to calculate area under curve (AUC).(
Composite measure)
|
0-240 min
|
Exercise intensity
Time Frame: 60 minutes
|
Sixty minute exercise protocol at minutes 60 to 120.
Oxygen consumption measured during exercise at 3 time points.
|
60 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Palatability of treatments
Time Frame: at 5 minutes
|
Measured by VAS questionnaire
|
at 5 minutes
|
Lactate concentration
Time Frame: 60 minutes
|
60 minute exercise protocol at minutes 60 to 120.
Measured before, during, and exercise exercise at 3 time points
|
60 minutes
|
Palatability of meal
Time Frame: at 260 minutes
|
Measured by VAS questionnaire
|
at 260 minutes
|
Physical comfort
Time Frame: 0-240 min
|
Measured by VAS questionnaire at 13 time points, used to calculate area under curve (AUC) (Composite measure)
|
0-240 min
|
Energy/fatigue
Time Frame: 0-240 min
|
Measured by VAS questionnaire at 13 time points, used to calculate area under curve (AUC) (Composite measure)
|
0-240 min
|
Heart rate
Time Frame: 60-120 min
|
Heart rate monitored over a 60 minute exercise protocol.
To monitor exercise intensity and give a measure of fatigue (cardiovascular drift)
|
60-120 min
|
Substrate Oxidation
Time Frame: 60 minutes
|
Measured during 60 minute exercise protocol at minutes 60-120.
Respiratory quotient measured during exercise at 3 time points.
|
60 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2015
Primary Completion (Actual)
July 1, 2017
Study Completion (Actual)
December 1, 2017
Study Registration Dates
First Submitted
December 17, 2014
First Submitted That Met QC Criteria
March 24, 2015
First Posted (Estimate)
March 30, 2015
Study Record Updates
Last Update Posted (Actual)
January 23, 2023
Last Update Submitted That Met QC Criteria
January 19, 2023
Last Verified
May 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- B2014:114-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Control
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryNot yet recruiting
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
National Taiwan University HospitalEnrolling by invitationCognitive Function | Atrial Fibrillation, PersistentTaiwan
-
Takeshi MorimotoUniversity of the RyukyusActive, not recruitingCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vanderbilt University Medical CenterCompleted